Additionally, the phosphorylation levels of AKT and PI3K in pancreatic cancer cells overexpressing CCNI2 were increased, and treatment with a PI3K inhibitor partially reversed this effect. This evidence concerns the gene CCNI2 and familial pancreatic carcinoma.